Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 7/20 | 0.80 |
| ▸ | FAAH | O00519 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | XBP1 | P17861 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.45 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16120722 | 1.00 | MGLL (0.80) | MGLLFAAHMAPK1ALDH1A1LMNA | |
| SCHEMBL155061 | 1.00 | MGLL (0.80) | MGLLFAAHMAPK1ALDH1A1LMNA | |
| SCHEMBL22311941 | 1.00 | MGLL (0.80) | MGLLFAAHMAPK1ALDH1A1LMNA | |
| SCHEMBL22311911 | 1.00 | MGLL (0.80) | MGLLFAAHMAPK1ALDH1A1LMNA | |
| SCHEMBL30831332 | 1.00 | MGLL (0.80) | MGLLFAAHMAPK1ALDH1A1LMNA | |
| SCHEMBL31647549 | 1.00 | MGLL (0.80) | MGLLFAAHMAPK1ALDH1A1LMNA | |
| SCHEMBL44460 | 0.98 | MGLL (0.76) | MGLLFAAHMAPK1ALDH1A1LMNA | |
| SCHEMBL140275 | 0.89 | MGLL (1.00) | MGLLFAAHMAPK1ALDH1A1LMNA | |
| SCHEMBL349749 | 0.89 | MGLL (1.00) | MGLLFAAHMAPK1ALDH1A1LMNA | |
| SCHEMBL15082420 | 0.89 | MGLL (1.00) | MGLLFAAHMAPK1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120078903-A | Ferritin nano-composite based on PROTAC and platinum drug synergistic effect and application thereof | 中原纳米酶实验室 | 2025-06-03 | — | — | CN | claimed |
| CN-108289820-B | Method for cosmetic treatment of keratin materials | 莱雅公司 | 2021-07-13 | — | — | CN | claimed |
| EP-2140270-A1 | METHOD OF MASS SPECTROMETRY | Micromass UK Limited (GB) | 2010-01-06 | — | — | EP | claimed |
| WO-2008125821-A1 | METHOD OF MASS SPECTROMETRY | MICROMASS UK LIMITED (GB) | 2008-10-23 | — | — | WO | claimed |
| WO-2025134068-A1 | ANTIBODY DRUG CONJUGATES TARGETING PROTEINOPATHIES, AND USES THEREOF | AC IMMUNE SA (CH) | 2025-06-26 | — | — | WO | disclosed |
| CN-120078903-A | Ferritin nano-composite based on PROTAC and platinum drug synergistic effect and application thereof | 中原纳米酶实验室 | 2025-06-03 | — | — | CN | disclosed |
| CN-119925628-A | Albumin fixed-point modified lipid nanoparticle and preparation and application thereof | 苏州大学 | 2025-05-06 | — | — | CN | disclosed |
| CN-108822267-B | preparation and application of pH-responsive protein macromolecule amphiphile | 清华大学 | 2022-12-16 | — | — | CN | disclosed |
| CN-108289820-B | Method for cosmetic treatment of keratin materials | 莱雅公司 | 2021-07-13 | — | — | CN | disclosed |
| CN-108822267-A | preparation and application of pH-responsive protein macromolecule amphiphile | 清华大学 | 2018-11-16 | — | — | CN | disclosed |
| EP-3337816-A1 | ALBUMIN VARIANTS AND CONJUGATES | Albumedix A/S (DK) | 2018-06-27 | — | — | EP | disclosed |
| US-20170320965-A1 | PAN-REACTIVE ANTIBODIES TO DUOCARMYCINS | SYNTHON BIOPHARMACEUTICALS B.V. (NL) | 2017-11-09 | — | — | US | disclosed |
| WO-2006069344-A2 | CONTROLLED RELEASE HYDROGELS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2006-06-29 | — | — | WO | disclosed |
| US-20060121452-A1 | Methods for detection of genetic disorders | RAVGEN, INC. (US) | 2006-06-08 | — | — | US | disclosed |
| EP-1434791-A4 | SPECIFIC BINDING AGENTS OF HUMAN ANGIOPOIETIN-2 | AMGEN INC (US) | 2006-04-26 | — | — | EP | disclosed |
| EP-1615952-A2 | METHODS OF TREATMENT OF INFLAMMATORY DISEASES USING SPECIFIC BINDING AGENTS OF HUMAN ANGIOPOIETIN-2 | Amgen Inc. (US) | 2006-01-18 | — | — | EP | disclosed |
| WO-2005000902-A1 | THE DIMER OF CHIMERIC RECOMBINANT BINDING DOMAIN-FUNCTIONAL GROUP FUSION FORMED VIA DISULFIDE-BOND-BRIDGE AND THE PROCESSES FOR PRODUCING THE SAME | CHOE MU-HYEON (KR) | 2005-01-06 | — | — | WO | disclosed |
| WO-2004092215-A2 | METHODS OF TREATMENT OF INFLAMMATORY DISEASES USING SPECIFIC BINDING AGENTS OF HUMAN ANGIOPOIETIN-2 | AMGEN INC. (US) | 2004-10-28 | — | — | WO | disclosed |
| EP-1434791-A2 | SPECIFIC BINDING AGENTS OF HUMAN ANGIOPOIETIN-2 | Amgen, Inc. (US) | 2004-07-07 | — | — | EP | disclosed |
| WO-2003057134-A2 | SPECIFIC BINDING AGENTS OF HUMAN ANGIOPOIETIN-2 | AMGEN, INC. (US) | 2003-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170320965-A1 | PAN-REACTIVE ANTIBODIES TO DUOCARMYCINS | GANAB, CNDP2, CD38 | MGLL 4080/4885FAAH 3181/4885MAPK1 4033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.